Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SorCape in Metastatic Colorectal Cancer
NCT01471353Phase 2Completed
- Sponsor
- University of Florida
- Start
- Nov 2011
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in colorectal cancer (metastatic) (mCRC), sponsored by University of Florida. Started Nov 2011; status: completed.
02
Drugs
sorafenib
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01471353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471353.